Differential expression of peroxiredoxin subtypes in human brain cell types

Journal of Neuroscience Research

Volumn 56, Issue 2, 1999, Pages 206-212

  Sarafian, Theodore A ^a   Verity, M Anthony ^a   Vinters, Harry V ^a   Shih, Charles C Y ^b   Shi, Liangru ^b   Ji, Xiang Dong ^b   Dong, Lingpu ^b   Shau, Hungyi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BD Technologies   (United States)

Author keywords

Antioxidant; Human brain; Immunohistochemistry; Neurons; Peroxiredoxin

Indexed keywords

ANTIOXIDANT; GENE PRODUCT; PEROXIREDOXIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN CORTEX; BRAIN NERVE CELL; CELL TYPE; CEREBELLUM; CONTROLLED STUDY; EPENDYMA CELL; GRANULE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; PYRAMIDAL NERVE CELL; SPINAL CORD; SUBSTANTIA NIGRA;

ADULT; ANIMALS; BRAIN; CELLS, CULTURED; HUMANS; MICE; MICE, INBRED BALB C; MIDDLE AGED; PEROXIDASES; SPINAL CORD;

EID: 0033135247     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR10>3.0.CO;2-X     Document Type: Article

References (48)

1. Ahn SM, Lee SM, Chung T, Kim K, Park JW. 1996. Yeast thiol-dependent protector protein expression enhances the resistance of Escherichia coli to hydrogen peroxide. Biochem Mol Biol Int 39:1007-1015.
2. Baldwin AS Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann Rev Immunol 14:649-683.
3. Beal MF. 1996. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 6:661-666.
4. Bondy SC, LeBel CP. 1993. The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Rad Biol Med 14:633-642.
5. Chae HZ, Kim I, Kim K, Rhee SG. 1993. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem 268:16815-16821.
6. Dawson VL, Dawson TM. 1996. Nitric oxide actions in neurochemistry. Neurochem Int 2:97-110.
7. Desagher S, Glowinski J, Premont J. 1996. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553-2562.
8. Geremia E, Baratta D, Zafarana S, Giordano R, Pinizzotto MR, La Rosa MG, Garozzo A. 1990. Antioxidant enzymatic systems in neuronal and glial cell-enriched fractions of rat brain during aging. Neurochem Res 7:719-723.
9. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 5:1609-1623.
10. Hossmann KA. 1997. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 2:95-101.
11. Ichimiya S, Davis JG, O'Rourke DM, Katsumata M, Greene MI. 1997. Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol 3:311-321.
12. Jenner P. 1998. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders 13(Suppl 1):24-34.
13. Jin DY, Chae HZ, Rhee SG, Jeang KT. 1997. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 49:30952-30961.
14. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. 1998. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 273:6297-6302.
15. Kim AT, Sarafian TA, Shau H. 1997. Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide. Toxicol Appl Pharmacol 147:135-42.
16. 3+, or 2-mercaptoethanol. Proc Natl Acad Sci USA 86:6018-6022.
17. Kim K, Kim I, Lee K, Rhee S G, Stadlman E R. 1988. The isolation and purification of a thiol-specific protector protein which inhibits enzyme inactivation by a thiol/Fe(III)/O mixed-function oxidation system. J Biol Chem 263:4707-4711.
18. Kucukkaya B, Aker R, Yuksel M, Onat F, Yalcin AS. 1998. Low dose MK-801 protects against iron-induced oxidative changes in a rat model of focal epilepsy. Brain Res 788:133-136.
19. Lim Y, Cha M, Kim H, Kim H. 1994. The thiol-specific antioxidant protein from human brain: gene cloning and analysis of conserved cysteine regions. Gene 140:279-284.
20. Lipton SA. 1993. Molecular mechanisms of trauma-induced neuronal degeneration. Curr Opin Neurol Neurosurg 6:588-596.
21. Liu D. 1996. The roles of free radicals in amyotrophic lateral sclerosis. J Mol Neurosci 7:159-167.
22. Marini AM, Kozuka M, Lipsky RH, Nowak TS Jr. 1990. 70-kilodalton heat shock protein induction in cerebellar astrocytes and cerebellar granule cells in vitro comparison with immunocytochemical localization after hyperthermia in vivo. J Neurochem 54:1509-1516.
23. Marmillot P, Scovell W. 1998. Enhancement of transcription factor, USF, binding to the adenovirus major late promoter: effect of dithiothreitol and high mobility group protein-1. Biochim Biophys Acta 1395:228-236.
24. Montgomery EB Jr. 1995. Heavy metals and the etiology of Parkinson's disease and other movement disorders. Toxicol 97:3-9.
25. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, Beyreuther K. 1997. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 54:533-539.
26. Netto LES, Chae HZ, Kang SW, Rhee SG, Stadtman ER. 1996. Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J Biol Chem 271:15315-15321.
27. Nishimura RN, Dwyer BE, Clegg K, Cole R, de Vellis J. 1991. Comparison of the heat shock response in cultured cortical neurons and astrocytes. Mol Brain Res 9:39-45.
28. Olanow CW, Arendash GW. 1994. Metals and free radicals in neurodegeneration. Curr Opin Neurol 7:548-558.
29. Parkinson JF, Mitrovic B, Merrill J. 1997. The role of nitric oxide in multiple sclerosis [see comments]. J Mol Med 75:174-186.
30. Philbert MA, Beiswanger CM, Waters DK, Reuhl KR, Lowndes HE. 1991. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol Appl Pharmacol 107:215-227.
31. Pulsinelli WA, Brierley JB. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272.
32. Reiter RJ. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9:526-533.
33. Rhee SG, Kim KH, Chae HZ, Yim MB, Uchida K, Netto LE, Stadtman ER. 1994. Antioxidant defense mechanisms: a new thiol-specific antioxidant enzyme. Ann NY Acad Sci 738:86-92.
34. Sarafian TA, Bredesen DE, Verity MA. 1996. Cellular resistance to methylmercury. Neurotoxicol 17:27-36.
35. Sarafian TA, Rajper N, Grigorian B, Kim A, Shau H. 1997. Cellular antioxidant properties of human natural killer enhancing factor B. Free Rad Res 26:281-289.
36. Sarafian TA, Huang C, Kim A, de Vellis J, Shau H. 1998. Expression of the antioxidant gene nkef in the central nervous system. Mol Chem Neuropathol 34:39-51.
37. Sauri H, Butterfield L, Kim A, Shau H. 1995. Antioxidant function of recombinant human natural killer enhancing factor. Biochem Biophys Res Commun 208:964-969.
38. Sauri H, Ashjian PH, Kim AT, Shau, H. 1996. Recombinant natural killer enhancing factor augments natural killer cytotoxicity. J. Leuk Biol 59:925-931.
39. Schapira AH. 1996. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 9:260-264.
40. Schwartz JL, Antoniades DZ, Zhao S. 1993. Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann NY Acad Sci 686:262-278.
41. Sen CK, Packer L. 1996. Antioxidant and redox regulation of gene transcription [see comments]. FASEB J 10:709-720.
42. Shau H, Gupta RK, Golub SH. 1993. Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell Immunol 147:1-11.
43. Shau H, Kim AT, Hedrick CC, Lusis AJ, Tompkins C, Finney R, Leung DW, Paglia DE. 1997. Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Rad Biol Med 22:497-507.
44. Shau H, Butterfield LH, Chiu R, Kim A. 1994. Cloning and sequence analysis of candidate human natural killing-enhancing factor genes. Immunogen 40:129-134.
45. Siesjo BK. 1981. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155-185.
46. Simonian NA, Coyle JT. 1996. Oxidative stress in neurodegenerative diseases. Ann Rev Pharmacol Toxicol 36:83-106.
47. Wen ST, van Etten. 1997. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Gen Dev 11:2456-2467.
48. Zhang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM. 1997. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272:30615-30618.